Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Abstract Text:

T Iizuka,F Sakai,T Ide,T Monzen,S Yoshii,M Iigaya,K Suzuki,D R Lynch,N Suzuki,T Hata,J Dalmau,

OBJECTIVE: To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic encephalitis" of unclear etiology, and to describe their long-term follow-up in the absence of tumor resection. METHODS: We extensively reviewed the case histories with current clinical and laboratory evaluations that include testing for antibodies to NR1/NR2 heteromers of the NMDAR in serum/CSF available from the time of symptom onset (4 to 7 years ago) and the present. RESULTS: All patients sequentially developed prodromal symptoms, psychosis, hypoventilation, severe orofacial dyskinesias, and bizarre immunotherapy-resistant involuntary movements that lasted 1 to 12 months. Two patients required mechanical ventilation for 6 and 9 months. Initial tests were normal or unrevealing, including the presence of nonspecific CSF pleocytosis, and normal or mild changes in brain MRI. Eventually, all patients had dramatic recovery of cognitive functions, although one had bilateral leg amputation due to systemic complications. Antibodies to NR1/NR2 heteromers were found in archived serum or CSF but not in long-term follow-up samples. An ovarian teratoma was subsequently demonstrated in three patients (all confirmed pathologically). CONCLUSION: 1) These findings indicate that "juvenile acute nonherpetic encephalitis" or a subset of this disorder is mediated by an antibody-associated immune response against NR1/NR2 heteromers of the NMDA receptor (NMDAR). 2) Our patients' clinical features emphasize that anti-NMDAR encephalitis is severe but potentially reversible and may precede by years the detection of an ovarian teratoma. 3) Although recovery may occur without tumor removal, the severity and extended duration of symptoms support tumor removal.

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Publishing Authors By Initials

T Iizuka,F Sakai,T Ide,T Monzen,S Yoshii,M Iigaya,K Suzuki,DR Lynch,N Suzuki,T Hata,J Dalmau,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Neurology

VOLUME: 70

Page Numbers: 504-11

Journal Abbreviation: Neurology

ISSN: 1526-632X

DAY: 26

MONTH: 09

YEAR: 2007

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 401060

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

AFFILIATION: Department of Neurology, School of Medicine, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa, 228-8555, Japan. takahiro@med.kitasato-u.ac.jp

Country: United States

AGENCY: United States NCI

GRANT: R01CA89054

ACRONYM: CA

MEDLINETA: Neurology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal Related Publications

• A patient with encephalitis associated with NMDA receptor antibodies.
• Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis.
• Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.
• Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.
• Frequent IgE sensitization to latex, cow's milk, and egg in children with short bowel syndrome.
• Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass.
• Inverse Ocular Bobbing in a Patient With Encephalitis Associated With Antibodies to the N-methyl-D-aspartate Receptor.
• Limbic encephalitis and variants: classification, diagnosis and treatment.
• Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis.
• Neuronal surface antigen antibodies in limbic encephalitis: Clinical-immunologic associations.
• Paraneoplastic disorders of the memory and cognition: clinical aspects and therapeutic approaches.
• Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.
• The E. Graeme Robertson Lecture Neurological paraneoplastic syndromes: a review of diagnosis and prospects for therapy.
• Thymoma, myasthenia gravis, encephalitis, and a novel anticytoplasmic neuronal antibody.
• [Antineural antibodies and paraneoplastic neurologic syndromes]
• [Classic paraneoplastic syndromes: diagnostic and treatment approach.]
• [Laryngeal paraganglioma: diagnosis and treatment. A propos of a case]
• [Neurological complications of transplantation.]
• [Patient satisfaction in a home enteral nutrition program]